Indeed, changes in blood BDNF levels have been associated with a number of neurological diseases including AD (Laske et al., 2006), and they have also been more frequently reported days or weeks after stimulation following tDCS in different clinical conditions or experimental models (Brunoni et al., 2015). This evidence concerns the gene BDNF and Alzheimer disease.